Centene appoints Cressey’s Paul Diaz to board as Burdick retires

PUBT · 3d ago
Centene appoints Cressey’s Paul Diaz to board as Burdick retires
  • Centene disclosed board changes effective July 28, 2026.
  • Kenneth A. Burdick retired from the board; he joined in January 2022.
  • Paul J. Diaz joined the board; he is managing partner at Cressey & Company.
  • Diaz previously led Myriad Genetics as CEO; earlier served as CEO of Kindred Healthcare.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centene Corporation published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.